Skip to Content

SATURDAY, 10 DECEMBER 2016, 16:35


STI apps may have inaccurate, harmful information

Today at 00:11 AM, via Reuters

(Reuters Health) – Of nearly 90 mobile phone apps focusing on sexually transmitted infections (STIs), about a third had inaccurate and incomplete information in a recent study.

New diabetes guidelines imminent, Jardiance sales may surge

Yesterday at 22:42 PM, via Reuters

(Reuters) – Two leading U.S. medical societies are poised in the coming weeks to issue new diabetes treatment guidelines reflecting the lifesaving cardiovascular effects of Eli Lilly’s Jardiance in a move expected to drive up the drug’s sales.

Big price hikes seen in drug that prevents overdose deaths

Yesterday at 22:35 PM, via Reuters

(Reuters Health) – Two of the largest suppliers of the life-saving drug naloxone have dramatically increased their prices in recent years, threatening to make it less likely that someone can be saved from a potentially-fatal opioid overdose.

Experts believe we’ll have an Alzheimer’s drug by 2025

Yesterday at 22:02 PM, via CNN

The results of recent trials that tested much-anticipated Alzheimer’s disease drugs dashed the hopes of patients with the debilitating condition. The most recent disappointment came from the large trial for solanezumab, by Eli Lilly, announced last month.

Buzz Aldrin released from hospital

Yesterday at 21:42 PM, via CNN

Former astronaut Buzz Aldrin has been released from a hospital in New Zealand and is on a flight back to the United States, according to a tweet from his manager, Christina Korp.

Anxiety, irritability may precede depression in high-risk teens

Yesterday at 21:14 PM, via Reuters

(Reuters Health) – When parents have a history of depression, teens are at greater risk for developing the disorder themselves, and signs of being irritable, anxious and fearful may precede a first episode of depression, a recent study suggests.

Optimistic women may live longer

Yesterday at 19:47 PM, via Reuters

(Reuters Health) – Women who have a sunny outlook on life may live longer than their peers who take a dimmer view of the world, a recent study suggests.

AstraZeneca’s immunotherapy enters U.S. approval process

Yesterday at 19:05 PM, via Reuters

FRANKFURT (Reuters) – AstraZeneca’s immunotherapy drug durvalumab, the British drugmaker’s most important pipeline medicine, has been accepted for review by U.S. regulators against bladder cancer, potentially its first use.

Scalp cooling device helps prevent hair loss from chemo

Yesterday at 18:56 PM, via Reuters

(Reuters Health) – A scalp-cooling system helped prevent hair loss in women with breast cancer undergoing chemotherapy, researchers said today at the San Antonio Breast Cancer Symposium.

How executions go wrong

Yesterday at 18:01 PM, via CNN

CNN’s Alexandra Field looks at the most common forms of execution used in the U.S. and how they can go wrong.

  1. Pages:
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. ...
  8. 15